¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"exposure keratitis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® keratitis ÇÑ±Û °¢¸·¿°
¼³¸í   
  °¢¸·ÀÇ ¿°Áõ. °¢¸·Àº Åõ¸íÇ졒ʡ¡¿îµ¥°¡ º¼·ÏÇϰԠ³ª¿Â Á¶Á÷À̸ç, ±× ºÎºÐ¿¡ °áÇÙ, ¸Åµ¶ µî Àü½Å¼º Àü¿°º´À̳ª Æ®¶óÄÚ¸¶, À¯Ç༺ °á¸·¿° µî ´«ÀÇ Àü¿°º´, ´«ÀÌ ¹Þ´Â ¹°¸®Àû-È­ÇÐÀû ÀÚ±Ø(¿Ü»óÀ̳ª »ê-¾ËÄ®¸® µî) µîÀÌ ¿øÀÎÀÌ µÇ¾î º¯È­¸¦ ÀÏÀ¸Å°´Â º´ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exposure keratitis
    ³ëÃâ°¢¸·¿°
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accidental exposure
    »ç°íÇÇÆø, »ç°í³ëÃâ
  • acute exposure
    ±Þ¼º³ëÃâ
  • cumulative glycemic exposure
    ´©Àû°íÇ÷´ç³ëÃâ
  • chronic exposure
    ¸¸¼º³ëÃâ
  • double exposure technique
    Áߺ¹X¼±ÃÔ¿µ(¼ú)
  • exposure
    1. ³ëÃâ 2. Á¶»ç 3. Á¶»ç¼±·® 4. Æø·Î 5. ÇÇÆø
  • exposure dose
    Æø·Î¼±·®
  • exposure rate
    ³ëÃâ·ü, ÇÇÆø·ü
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
  • exposure ratio
    ³ëÃâºñÀ²
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
  • exposure-odds ratio
    ³ëÃâ±³Â÷ºñ
  • public exposure
    °ø°øÇÇÆø, °ø°ø³ëÃâ
  • permissible exposure limit
    Çã¿ë³ëÃâÇѰè, Çã¿ëÇÇÆøÇѰè
  • permissible radiation exposure level
    Çã¿ë¹æ»ç¼±ÇÇÆø¼±·®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • keratitis
    °¢¸·¿°
  • exposure
    ³ëÃâ
  • occupational exposure
    Á÷¾÷³ëÃâ
  • public exposure
    °øÁßÇÇÆø, °øÁß³ëÃâ
  • radiation exposure
    ¹æ»ç¼±³ëÃâ
  • sun exposure
    Àϱ¤³ëÃâ
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exposure keratitis
    ³ëÃâ°¢¸·¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accidental exposure
    »ç°íÇÇÆø, »ç°í³ëÃâ
  • acute exposure
    ±Þ¼ºÇÇÆø, ±Þ¼º³ëÃâ
  • chronic exposure
    ¸¸¼ºÇÇÆø, ¸¸¼º³ëÃâ
  • cumulative glycemic exposure
    ´©Àû°íÇ÷´ç³ëÃâ
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
  • double exposure technique
    Áߺ¹¿¢½º¼±ÃÔ¿µ¼ú
  • exposure dose
    Æø·Î¼±·®
  • exposure
    ³ëÃâ
  • exposure rate
    ÇÇÆø·ü
  • exposure ratio
    ³ëÃâºñÀ²
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
  • exposure-odds ratio
    ³ëÃâ±³Â÷ºñ
  • occupational exposure
    Á÷¾÷³ëÃâ
  • prolonged exposure
    Àå±â³ëÃâ
  • public exposure
    °øÁßÇÇÆø, °øÁß³ëÃâ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accidental exposure
    »ç°í½ÃÇÇÆø, °ú½ÇÇÇÆø
  • acute exposure
    ±Þ¼ºÇÇÆø
  • prolonged exposure
    Àå±â³ëÃâ.
  • public exposure
    °øÁßÇÇÆø
  • Thygesons superficial punctate keratitis
    ŸÀ̰Ž¼Ç¥ÃþÁ¡»ó°¢¸·¿°
  • acne rosacea keratitis
    µþ±âÄÚ°¢¸·¿°
  • actinic keratitis
    ±¤È­Çа¢¸·¿°(í¹èâàÊÊÇØ¯æú).
  • allergic keratitis
    ¾Ë·¹¸£±â°¢¸·¿° (ÊÇØ¯æú).
  • herpes keratitis
    Ç츣Æä½º°¢¸·¿°, Æ÷Áø°¢¸·¿°
  • herpes simplex keratitis
    ´Ü¼øÆ÷Áø°¢¸·¿°.
  • herpetic keratitis
    Ç츣Æä½º°¢¸·¿°, Æ÷Áø°¢¸·¿°.
  • phlyctenular keratitis
    Çø¯ÅÙ°¢¸·¿°(¡­ÊÇØ¯æú).
  • phlyctenular keratitis
    Çø¯ÅÙ¼º °¢¸·¿°(¡­àõ ÊÇØ¯æú)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exposure keratitis
    ³ëÃâ°¢¸·¿°(ÖÚõóÊÇØ¯æú).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • scrofulous keratitis->phlyctenular keratitis
    ÇÁ¸¯ÅÙ°¢¸·¿°(ÊÇØ¯æú).
  • accidental exposure
    »ç°í½ÃÇÇÆø, °ú½ÇÇÇÆø
  • acute exposure
    ±Þ¼ºÇÇÆø
  • chemical exposure
    È­ÇÐÀû ³ëÃâ<Æø·Î
  • chronic exposure
    ¸¸¼ºÇÇÆø
  • continuous exposure
    ¿¬¼ÓÇÇÆø
  • double exposure technique
    Áߺ¹ X¼±ÃÔ¿µ¼ú
  • exposure
    ÇÇÆø
  • exposure calibration factor
    ÇÇÆøÃøÁ¤°è¼ö
  • exposure dose
    Á¶»ç·®.
  • exposure keratopathy
    ³ëÃâ°¢¸·º´Áõ
  • exposure meter
    ³ëÃâ°è(ËȨ̀˭).
  • exposure of person
    ½Åü ³ëÃâ.
  • exposure rate
    ÇÇÆøÀ²
  • exposure rate constant
    ÇÇÆøÀ²»ó¼ö
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acanthamoeba keratitis
    °¡½Ã¾Æ¸Þ¹Ù°¢¸·¿°
  • amebic keratitis
    ¾Æ¸Þ¹Ù°¢¸·¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exposure dose
    ³ëÃâ·®(ÖÚõóÕá)
  • gaseous exposure method
    °³½º ³ëÃâ¹ý(ÖÚõóÛö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • keratitis
    °¢¸·¿°
  • double exposure technique
    Áߺ¹X¼±ÃÔ¿µ¼ú
  • exposure
    ³ëÃâ, Æø·Î, Á¶»ç
  • exposure time
    ³ëÃâ½Ã°£, Á¶ ½Ã°£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HSK herpes simplex keratitis
IK immobilized knee; immune body [Ger. Immunekorper]; Infusoria killing [unit]; interstitial keratitis
Kera keratitis
KID keratitis, ichthyosis, and deafness [syndrome]
KP Kaufmann-Peterson [base]; keratitic precipitate; keratitis punctata; kidney protein; killed parenter...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HSK Herpes Simplex Keratitis
HSK Herpetic stromal keratitis
PUK Peripheral ulcerative keratitis
AEC Automatic Exposure Control
B.E.I. Biological Exposure Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fungal keratitis
    Áø±Õ¼º °¢¸·¿°
    ½Ä¹°¼º ¹°ÁúÀ» Æ÷ÇÔÇÑ °¢¸· ¼Õ»ó ÈÄ¿¡¼­³ª ³óºÎ³ª ¸é¿ª ÀúÇÏ È¯ÀÚ¿¡¼­ »ý±â±â ½±´Ù. Áõ»óÀÌ ¾ø´Â °æ¿ìµµ ÀÖ´Ù. °¢¸·¿¡´Â Ư¡ÀûÀ¸·Î ºñ±³Àû »óÇÇ ¼Õ»óÀÌ ¾øÀÌ ´Ù¼öÀÇ ½ÇÁú¼º ³ó¾çÀÌ »ý±ä´Ù. ¾È±¸ ³» ¿°ÁõÀÌ ÀÇ½ÉµÉ ¶§´Â ¹Ýµå½Ã °¢¸· Âû°ú Ç¥º»À» äÃëÇÏ¿© Áø±Õ ¹è¾ç¿¡ ÀûÇÕÇÑ ¹èÁö¿¡ ¹è¾ç½ÃŲ´Ù.
  • herpes simplex keratitis
    ´Ü¼ø Æ÷Áø °¢¸·¿°
  • interstitial keratitis
    ½ÇÁú¼º °¢¸·¿°, °£Áú¼º °¢¸·¿°
    °¢¸·ÀÇ ½ÇÁú ½ÉºÎ¿¡ Ä§Âø¹°ÀÌ »ý±â´Â ¸¸¼º °¢¸·¿°À¸·Î ¿©·¯ ÇüÀÌ ÀÖ´Ù. °¢¸·Àº ¶Ñ·ÇÇÏÁö ¾Ê°í ¾È°³°¡ ³¤ °Í °°Àº ¹«±¤ÅÃÀÇ À¯¸® ¸ð¾çÀ¸·Î µÈ´Ù. ÀÌ ÁúȯÀº ¼±Ãµ¼º ¸Åµ¶À¸·Î º´¹ßµÇ¸ç 15¼¼ ÀÌÀüÀÇ ¼Ò¾Æ¿¡°Ô »ý±ä´Ù.
  • intertitial keratitis
    ½ÇÁú¼º °¢¸·¿°
  • keratitis
    °¢¸·¿°
    °¢¸·ÀÇ ¿°Áõ. °¢¸·Àº Åõ¸íÇÏ°í °¡¿îµ¥°¡ º¼·ÏÇÏ°Ô ³ª¿Â ¸ð¾çÀ» ÇÑ Á¶Á÷Àε¥, ±× ºÎºÐ¿¡ °áÇÙ, ¸Åµ¶ µî Àü½Å¼º Àü¿°º´À̳ª Æ®¶óÄÚ¸¶, À¯Ç༺ °á¸·¿° µî ´«ÀÇ Àü¿°º´, ´«ÀÌ ¹Þ´Â ¹°¸®Àû, È­ÇÐÀû ÀÚ±Ø
  • keratitis bullosa
    ´ë¼öÆ÷¼º °¢¸·¿°, ¼öÆ÷»ó °¢¸·¿°
    °¢¸· »ó¿¡ Å©°í ÀÛÀº ¼öÆ÷°¡ Çü¼ºµÇ´Â °Í.
  • keratitis nodosa
    °áÀý»ó °¢¸·¿°
  • keratitis petrificans
    ¼®È­¼º °¢¸·¿°
    ¼®È¸ÁúÀÇ º¯È­¸¦ ±¸¹ÝÇÏ´Â °¢¸·¿°.
  • keratitis punctata
    Á¡»ó °¢¸·¿°
    °¢¸·ÀÇ Èĸ鿡 »ý±â´Â ¼¼Æ÷¼º ¹× ¼¶À¯¼º Ä§Âø¹°ÀÇ Çü¼º¿¡ ´ëÇÑ ¿¾ ¸íĪÀ¸·Î¼­ ¼Õ»óÀ̳ª ȫä ¸ð¾çü¿° ÈÄ¿¡ ¹ß»ýÇÏ°í ¶ÇÇÑ À̽½ °°Àº ÀÛÀº ¹æ¿ï ¸ð¾çÀ» ³ªÅ¸³½´Ù.
  • keratitis pustuliformis profunda
    ½ÉÀç ³óÆ÷¼º °¢¸·¿°
    µ¿ÅëÀ» ¼ö¹ÝÇÏ´Â °¢¸·¿°À¸·Î¼­ °¢¸· ½ÉºÎ¿¡ Ȳ»öÀÇ Á¡»ó ȥŹÀÌ »ý±â¸ç, Àü¹æ Ãà³ó, È­³ó¼º ȫä¿°À» ¼ö¹ÝÇÑ´Ù.
  • keratitis secca
    °Ç¼º °¢¸·¿°
  • mycotic keratitis
    Áø±Õ¼º °¢¸·¿°
  • neuroparalytic keratitis
    ½Å°æ ¸¶ºñ¼º °¢¸·¿°, ¿µ¾ç ½Å°æ¼º °¢¸·¿°
    »ïÂ÷ ½Å°æÀÇ Àå¾Ö·Î, ¾È°ËÀÇ Æó¼â¿¡ ÁöÀåÀ» ¹ÞÀ¸¸ç °¢¸· »óÇÇ¿¡´Â °ÇÁ¶¿Í ±Õ¿­ÀÌ »ý±â´Â »óÅÂ.
  • ribbon like keratitis
    ´ë»ó °¢¸·¿°
  • sclerosing keratitis
    °æÈ­¼º °¢¸·¿°
    ºñÈļº °ø¸·¿°À» ¼ö¹ÝÇÏ´Â °¢¸·¿°.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
exposure keratitis Inflammation of the cornea resulting from irritation caused by inability to close the eyelids.
Synonym: lagophthalmic keratitis.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
maternal exposure Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure.
(12 Dec 1998)
maximum permissible exposure level The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury.
(12 Dec 1998)
paternal exposure Exposure of the male parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring.
(12 Dec 1998)
permissible exposure limit An occupational health standard to safeguard workers against dangerous contaminants in the workplace.
(05 Mar 2000)
prenatal exposure delayed effects Delayed effects on offspring of maternal or foetal prenatal exposure to drugs, radiation and other physical agents, manipulation, nutrition, stress, etc.
(12 Dec 1998)
short-term exposure limit The maximum concentration of a chemical to which workers may be exposed continuously for up to 15 minutes without danger to health or work efficiency and safety.
(05 Mar 2000)
dental pulp exposure The result of pathological changes in the hard tissue of a tooth caused by carious lesions, mechanical factors, or trauma, which render the pulp susceptible to bacterial invasion from the external environment.
(12 Dec 1998)
inhalation exposure The exposure to potentially harmful chemical, physical, or biological agents by inhaling them.
(12 Dec 1998)
occupational exposure The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation.
(12 Dec 1998)
environmental exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals.
(12 Dec 1998)
exposure <radiobiology> A quantitative measure of x or gamma radiation at a certain place, based on its ability to produce ionisation in air. The former special unit of exposure was the roentgen (R). 1R = 2.58 x 10-4 C/kg. In the international system (SI unit), the special unit is coulomb per kilogram. (Exposure also is frequently used as a synonym for irradiation).
(16 Dec 1997)
exposure dose The radiation dose, expressed in roentgens, delivered at a point in free air.
Synonym: air dose.
(05 Mar 2000)
exposure odds ratio <epidemiology> See Odds ratio.
(05 Dec 1998)
acanthamoeba keratitis Infection of the cornea by an ameboid protozoan which may cause corneal ulceration leading to blindness.
(12 Dec 1998)
actinic keratitis A reaction of the cornea to ultraviolet light.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • keratitis
    °¢¸·¿°
  • exposure
    ³ëÃâ
  • double exposure
    (»ç)ÀÌÁß ³ëÃâ
  • exposure
    ¹ö·ÁµÒ;(Áý,¹æÀÇ)Çâ;³ëÃâ;Æø·Î;Àû¹ß;(¾î¸°¾ÖÀÇ)À¯±â
  • exposure index
    ³ë±¤Áö¼ö
  • exposure meter
    ³ëÃâ°è
  • indecent exposure
    (¹ý)°ø°³Àû ¿Ü¼³ÁË
  • time exposure
    ŸÀÓ ³ëÃâ(ÀÇ »çÁø)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á